Monday, August 26, 2024
INOVAIT Canada, the IGT network hosted by SRI, releases first progress report
INOVAIT Canada, the country’s image-guided therapy (IGT) network hosted by Sunnybrook Research Institute, just released its first progress report: “2020-2023 Canada’s Image-Guided Therapy Sector: Supported by INOVAIT, Growing with Artificial Intelligence.”
The new publication highlights the ongoing advancements and technologies that are transforming Canada’s IGT and health care sectors.
Monday, August 26, 2024
Sunnybrook-led multicentre trial finds tranexamic acid increases postoperative complications in patients undergoing liver resection
Findings of the HeLiX Randomized Clinical Trial demonstrate that among patients undergoing liver resection for a cancer-related indication, tranexamic acid did not reduce bleeding or blood transfusion but increased perioperative complications.
Wednesday, August 21, 2024
‘The research marks you forever’: SRI students showcase their summer research projects
Undergraduate students across SRI and the Hurvitz Brain Sciences Program presented their summer research projects at the annual SRI Summer Student Poster Competition and the Hurvitz Brain Sciences Summer Student Presentation Day events last week, celebrating the finale in a summer’s worth of effort.
Friday, August 16, 2024
Improved continuity of care protective for persons with lower-extremity amputation
After a lower-extremity amputation (LEA), an improved continuity of clinical care – particularly integration within primary and specialist care – would better assist in the management of LEA and related conditions, suggests a new study.
Thursday, August 8, 2024
Common antibiotics carry small but serious risks of life-threatening drug reactions, but some are safer than others
Two classes of commonly-prescribed oral antibiotics are associated with the greatest risk for severe drug rashes that can lead to emergency department visits, hospitalizations and even death, according to a new study published in the journal JAMA.
